SciELO - Scientific Electronic Library Online

 
vol.18 número1Manifestaciones atípicas de la enfermedad de WhippleTriple asociación: espondiloartropatía seronegativa de inicio tardío, enfermedad de Paget y arteritis de células gigantes índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Anales de Medicina Interna

versión impresa ISSN 0212-7199

Resumen

DOMINGUEZ ORTEGA, J. et al. Hypersensitivity to allopurinol: Efficacy of desensitization procedure in three cases. An. Med. Interna (Madrid) [online]. 2001, vol.18, n.1, pp.27-28. ISSN 0212-7199.

Allopurinol is often prescribed for the treatment of hyperuricemia. It inhibits the uric acid production binding tightly to xanthine oxidase. Although it is generally well tolerated, an almost 10% prevalence of adverse reactions has been reported, particularly gastrointestinal and neurological effects. Some hypersensitivity syndromes have also been described (rash, vasculitis or exfoliative dermatitis). In these cases, if a substitute treatment is not available, a desensitization procedure to the drug must be considered. We present three patients with cutaneous hypersensitivity to allopurinol, two who developed urticaria and other one who had a fixed drug eruption. Skin test were all negatives with positive oral challenge test. An out- patient desensitization procedure to allopurinol was initiated, repeating the last tolerated doses for 4 or 5 days, and reaching maintenance therapeutic drug doses without any significant adverse effect (only one case of cutaneous pruritus).These experiences and the previously reported in the literature, show that the desensitization to allopurinol is a good therapeutic alternative in hypersensitivity reactions to the drug.

Palabras clave : Allopurinol; Allergy; Desensitization; Hyperuricemia.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons